Familial Tetralogy of Fallot caused by mutation in the jagged1 gene.

PubWeight™: 1.75‹?› | Rank: Top 3%

🔗 View Article (PMID 11152664)

Published in Hum Mol Genet on January 15, 2001

Authors

Z A Eldadah1, A Hamosh, N J Biery, R A Montgomery, M Duke, R Elkins, H C Dietz

Author Affiliations

1: Division of Cardiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Articles citing this

De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet (2009) 3.86

Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J Cell Biol (2008) 2.21

Alagille syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet (2011) 1.94

The Notch ligand Jagged1 is required for inner ear sensory development. Proc Natl Acad Sci U S A (2001) 1.64

Canonical and non-canonical Notch ligands. Curr Top Dev Biol (2010) 1.62

Murine Jagged1/Notch signaling in the second heart field orchestrates Fgf8 expression and tissue-tissue interactions during outflow tract development. J Clin Invest (2009) 1.50

Notch and disease: a growing field. Semin Cell Dev Biol (2012) 1.48

Consequences of JAG1 mutations. J Med Genet (2003) 1.44

Regulation of mammalian Notch signaling and embryonic development by the protein O-glucosyltransferase Rumi. Development (2011) 1.42

Transcription factor pathways and congenital heart disease. Curr Top Dev Biol (2012) 1.41

Novel resequencing chip customized to diagnose mutations in patients with inherited syndromes of intrahepatic cholestasis. Gastroenterology (2006) 1.35

RBPJ mutations identified in two families affected by Adams-Oliver syndrome. Am J Hum Genet (2012) 1.34

Loss of Gata5 in mice leads to bicuspid aortic valve. J Clin Invest (2011) 1.28

Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome. Development (2012) 1.21

The neural crest in cardiac congenital anomalies. Differentiation (2012) 1.17

Partitioning the heart: mechanisms of cardiac septation and valve development. Development (2012) 1.13

Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis. Hum Mutat (2010) 1.05

Stem cell models of cardiac development and disease. Annu Rev Cell Dev Biol (2010) 1.03

Familial deafness, congenital heart defects, and posterior embryotoxon caused by cysteine substitution in the first epidermal-growth-factor-like domain of jagged 1. Am J Hum Genet (2002) 1.02

Familial recurrence of congenital heart disease: an overview and review of the literature. Eur J Pediatr (2006) 1.00

Notch signaling in cardiac development and disease. Pediatr Cardiol (2009) 0.98

Notch signaling and Notch signaling modifiers. Int J Biochem Cell Biol (2011) 0.97

Role of glycans and glycosyltransferases in the regulation of Notch signaling. Glycobiology (2010) 0.97

A common variant in the PTPN11 gene contributes to the risk of tetralogy of Fallot. Circ Cardiovasc Genet (2012) 0.96

Conditional JAG1 mutation shows the developing heart is more sensitive than developing liver to JAG1 dosage. Am J Hum Genet (2003) 0.96

A variant in the carboxyl-terminus of connexin 40 alters GAP junctions and increases risk for tetralogy of Fallot. Eur J Hum Genet (2012) 0.94

Agenesis of the internal carotid artery: associated malformations including a high rate of aortic and cardiac malformations. Pediatr Radiol (2012) 0.93

Patterns of cardiac and extracardiac anomalies in adults with tetralogy of fallot. Am Heart J (2011) 0.90

Notch1 is pan-endothelial at the onset of flow and regulated by flow. PLoS One (2015) 0.85

DNA methylation status of NKX2-5, GATA4 and HAND1 in patients with tetralogy of fallot. BMC Med Genomics (2013) 0.83

SNP genotyping to screen for a common deletion in CHARGE syndrome. BMC Med Genet (2005) 0.83

Association of promoter methylation statuses of congenital heart defect candidate genes with Tetralogy of Fallot. J Transl Med (2014) 0.83

Genetics and Genomics of Congenital Heart Disease. Circ Res (2017) 0.81

Jagged1 (JAG1): Structure, expression, and disease associations. Gene (2015) 0.80

Alagille syndrome: clinical perspectives. Appl Clin Genet (2016) 0.79

Alagille Syndrome: A New Missense Mutation Detected by Whole-Exome Sequencing in a Case Previously Found to Be Negative by DHPLC and MLPA. Mol Syndromol (2013) 0.78

Family Based Whole Exome Sequencing Reveals the Multifaceted Role of Notch Signaling in Congenital Heart Disease. PLoS Genet (2016) 0.77

Biological functions of fucose in mammals. Glycobiology (2017) 0.76

Connecting teratogen-induced congenital heart defects to neural crest cells and their effect on cardiac function. Birth Defects Res C Embryo Today (2014) 0.76

Insights from systems pharmacology into cardiovascular drug discovery and therapy. BMC Syst Biol (2014) 0.76

Blood Flow Patterns Underlie Developmental Heart Defects. Am J Physiol Heart Circ Physiol (2017) 0.76

Alagille syndrome and Wilson disease in siblings: a diagnostic conundrum. Can J Gastroenterol (2012) 0.75

Sarcoidosis in a young child with Alagille syndrome: a case report. Pediatr Rheumatol Online J (2012) 0.75

Long telomeres protect against age-dependent cardiac disease caused by NOTCH1 haploinsufficiency. J Clin Invest (2017) 0.75

Existence of mutations in the homeodomain-encoding region of NKX2.5 gene in Iranian patients with tetralogy of Fallot. J Res Med Sci (2016) 0.75

Tetralogy of Fallot and atrial septal defect in a white Bengal Tiger cub (Panthera tigris tigris). Acta Vet Scand (2014) 0.75

Constitutively active Notch1 signaling promotes endothelial‑mesenchymal transition in a conditional transgenic mouse model. Int J Mol Med (2014) 0.75

Human hepatic organoids for the analysis of human genetic diseases. JCI Insight (2017) 0.75

Heart failure in congenital heart disease: the role of genes and hemodynamics. Pflugers Arch (2014) 0.75

Gene expression analysis in cardiac tissues from infants identifies candidate agents for Tetralogy of Fallot. Pediatr Cardiol (2013) 0.75

Articles by these authors

Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature (1991) 11.44

Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet (1996) 7.84

Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet (1999) 6.90

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A (1997) 5.66

The surveillance complex interacts with the translation release factors to enhance termination and degrade aberrant mRNAs. Genes Dev (1998) 3.71

Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat Genet (1997) 2.98

A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest (1994) 2.98

Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet (2007) 2.91

A mutated human homologue to yeast Upf1 protein has a dominant-negative effect on the decay of nonsense-containing mRNAs in mammalian cells. Proc Natl Acad Sci U S A (1998) 2.87

A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition. Nat Biotechnol (2001) 2.82

C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant (2006) 2.81

Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci U S A (1999) 2.80

When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell (2001) 2.55

Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome. Sci Transl Med (2010) 2.55

The molecular genetics of Marfan syndrome and related disorders. J Med Genet (2006) 2.45

Expanding kidney paired donation through participation by compatible pairs. Am J Transplant (2007) 2.41

Rent1, a trans-effector of nonsense-mediated mRNA decay, is essential for mammalian embryonic viability. Hum Mol Genet (2001) 2.35

A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome. N Engl J Med (1994) 2.29

Mobilization of host stem cells enables long-term liver transplant acceptance in a strongly rejecting rat strain combination. Am J Transplant (2011) 2.26

Mammalian orthologues of a yeast regulator of nonsense transcript stability. Proc Natl Acad Sci U S A (1996) 2.24

Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody. Am J Transplant (2009) 2.22

Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome. Circ Res (2001) 2.22

Laparoscopic live donor nephrectomy: the recipient. Transplantation (2000) 2.11

Novel Upf2p orthologues suggest a functional link between translation initiation and nonsense surveillance complexes. Mol Cell Biol (2000) 2.07

Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet (2001) 2.07

Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5' end. Genomics (1993) 2.05

Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet (1995) 2.01

Quantifying the risk of incompatible kidney transplantation: a multicenter study. Am J Transplant (2014) 2.00

Behavioral and cognitive effects of caffeine in boys and adult males. J Nerv Ment Dis (1981) 1.90

Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%. Am J Hum Genet (1997) 1.84

Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis. Am J Transplant (2011) 1.84

Social media and organ donor registration: the Facebook effect. Am J Transplant (2013) 1.83

Cold ischemia time and allograft outcomes in live donor renal transplantation: is live donor organ transport feasible? Am J Transplant (2007) 1.81

Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis. Am J Transplant (2011) 1.75

The Marfan syndrome locus: confirmation of assignment to chromosome 15 and identification of tightly linked markers at 15q15-q21.3. Genomics (1991) 1.75

Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome. J Pediatr (2000) 1.74

Recurrent abdominal pain: a potential precursor of irritable bowel syndrome in adolescents and young adults. J Pediatr (1998) 1.71

Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. Circulation (2001) 1.69

Thiazide-induced hypokalemia. Association with acute myocardial infarction and ventricular fibrillation. JAMA (1978) 1.68

Listing for expanded criteria donor kidneys in older adults and those with predicted benefit. Am J Transplant (2010) 1.65

The roles of dominos and nonsimultaneous chains in kidney paired donation. Am J Transplant (2009) 1.61

Identifying appropriate recipients for CDC infectious risk donor kidneys. Am J Transplant (2013) 1.60

Sheep cardiac sarcoplasmic reticulum calcium-release channels: modification of conductance and gating by temperature. J Physiol (1991) 1.58

Laparoscopic live donor nephrectomy with vaginal extraction: initial report. Am J Transplant (2010) 1.56

Association between waiting times for kidney transplantation and rates of live donation. Am J Transplant (2007) 1.56

The hemodynamic response to chronic anemia. Circulation (1969) 1.56

A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa. Nat Genet (1993) 1.53

Effect modification in liver allografts with prolonged cold ischemic time. Am J Transplant (2008) 1.52

Hydroxocobalamin dose escalation improves metabolic control in cblC. J Inherit Metab Dis (2009) 1.47

New insights into the gating mechanisms of cardiac ryanodine receptors revealed by rapid changes in ligand concentration. Circ Res (1995) 1.44

Outcomes of kidneys from donors after cardiac death: implications for allocation and preservation. Am J Transplant (2007) 1.42

Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: genetic analysis of the virus and generation of a standardized challenge pool. J Infect Dis (1998) 1.38

Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet (1996) 1.38

Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene. Am J Hum Genet (1991) 1.35

Nonsense mutations and diminished mRNA levels. Nat Genet (1993) 1.34

The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection. Am J Transplant (2008) 1.34

Neuroradiologic manifestations of Loeys-Dietz syndrome type 1. AJNR Am J Neuroradiol (2009) 1.33

Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome. Nat Genet (1996) 1.31

Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis. Am J Transplant (2011) 1.31

Laparoscopic live donor nephrectomy removes disincentives to live donation. Transplant Proc (1997) 1.29

Both the wild type and a functional isoform of CFTR are expressed in kidney. Am J Physiol (1996) 1.27

Intracellular accumulation of beta-amyloid in cells expressing the Swedish mutant amyloid precursor protein. J Biol Chem (1995) 1.27

Laparoscopic live donor nephrectomy: the four year Johns Hopkins University experience. Nephrol Dial Transplant (1999) 1.26

Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes. J Virol (2001) 1.24

A loss-of-function mutation in the endothelin-converting enzyme 1 (ECE-1) associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction. Am J Hum Genet (1999) 1.21

Cytokine gene expression: analysis using northern blotting, polymerase chain reaction and in situ hybridization. Immunol Rev (1991) 1.21

Extracellular microfibrils in development and disease. Cell Mol Life Sci (2007) 1.21

Laparoscopic live donor nephrectomy. A review of the first 5 years. Urol Clin North Am (2001) 1.20

Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms. J Clin Invest (1994) 1.19

Natural history of nonketotic hyperglycinemia in 65 patients. Neurology (2004) 1.19

An improved apparatus for the optical recording of contraction of single heart cells. Pflugers Arch (1988) 1.16

Should the indications for laparascopic live donor nephrectomy of the right kidney be the same as for the open procedure? Anomalous left renal vasculature is not a contraindiction to laparoscopic left donor nephrectomy. Transplantation (2001) 1.14

Mutations in KRIT1 in familial cerebral cavernous malformations. Neurosurgery (2000) 1.12

Expression of APP in transgenic mice: a comparison of neuron-specific promoters. Neurobiol Aging (1996) 1.12

Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndrome. Hum Mol Genet (1993) 1.12

Inhibition of fibrillin 1 expression using U1 snRNA as a vehicle for the presentation of antisense targeting sequence. Hum Mol Genet (1997) 1.12

The effects of DonorNet 2007 on kidney distribution equity and efficiency. Am J Transplant (2009) 1.11

Family-based association mapping provides evidence for a gene for reading disability on chromosome 15q. Hum Mol Genet (2000) 1.11

The characterization of a monovalent cation-selective channel of mammalian cardiac muscle sarcoplasmic reticulum. J Membr Biol (1984) 1.10

Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant (2007) 1.10

Formal policies and special informed consent are associated with higher provider utilization of CDC high-risk donor organs. Am J Transplant (2008) 1.10

Donor horseshoe kidneys for transplantation. Transplantation (2001) 1.09

Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome. Am J Hum Genet (1998) 1.07

CFTR protein expression in primary and cultured epithelia. Proc Natl Acad Sci U S A (1992) 1.07

Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype. J Clin Invest (1995) 1.07

Estimating the potential pool of HIV-infected deceased organ donors in the United States. Am J Transplant (2011) 1.07

Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients. Am J Transplant (2010) 1.06

Inorganic membranes for hydrogen production and purification: a critical review and perspective. J Colloid Interface Sci (2007) 1.06

Laparoscopic live donor nephrectomy. Urol Clin North Am (1999) 1.05

The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection. Am J Transplant (2007) 1.05

The questioning skills of clinical teachers and preceptors: a comparative study. J Adv Nurs (2001) 1.05

Relationship of cytoplasmic granules in renal papillary interstitial cells to "postsalt" hypertension. J Lab Clin Med (1969) 1.05

Occurrence of indole-3-acetic Acid-producing bacteria on pear trees and their association with fruit russet. Phytopathology (1998) 1.05

Improving distribution efficiency of hard-to-place deceased donor kidneys: Predicting probability of discard or delay. Am J Transplant (2010) 1.04

A simple flow chart for use in cardiac arrest. JAMA (1967) 1.03

Bed rest in acute myocardial infarction: a study of physician practices. Am Heart J (1971) 1.03